### 20209 Federal Register / Vol. 79, No. 70 / Friday, April 11, 2014 / Notices

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention (CDC)** 

**[CDC–2014–0006, Docket Number NIOSH– 273]** 

**Notice of Draft Document for Public Comment** 

**AGENCY :**  National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION :**  Notice of draft document for public comment.

**SUMMARY :**  The National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention announces the availability of a draft method to be published in the NIOSH Manual of Analytical Methods (NMAM) entitled ‘‘Method 8324: 3- Bromopropionic acid in urine; A metabolite of 1-bromopropane’’ now available for public comment. To view the notice and related materials, visit http://www.regulations.gov and enter CDC–2014–0006 in the search field and click ‘‘Search.’’

Public comment period: Comments must be received June 10, 2014.

**ADDRESSES :**  You may submit comments, identified by CDC–2014–0006 and Docket Number NIOSH–273, by either of the following two methods:

• Federal eRulemaking Portal: https://www.regulations.gov Follow the instructions for submitting comments.

• Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C–34, Cincinnati, Ohio
45226.

Instructions: All information received in response to this notice must include the agency name and docket number [CDC–2014–0006; NIOSH–273]. All relevant comments received will be posted without change http:// www.regulations.gov, including any personal information provided. All information received in response to this notice will also be available for public examination and copying at the NIOSH Docket Office, 4676 Columbia Parkway, Room 109, Cincinnati, OH 45226.

**SUPPLEMENTARY INFORMATION :** 

Background: The NIOSH Manual of Analytical Methods (NMAM) was first published in 1974 and currently contains over 300 methods that can be used by the occupational safety and health community to measure worker exposures. 1-Bromopropane is an industrial solvent often used as a substitute for a number of chlorofluorocarbon solvents which were withdrawn from use because of their possible damaging effects to the ozone layer. 3-Bromopropionic acid is a human metabolite of 1-bromopropane and a proposed biomarker of exposure. An accurate and precise method was developed for the detection and quantitation of 3-bromopropionic acid in human urine. This method was published in the literature (B’Hymer CB, Cheever KL [2004]. J Chromatogr B 802:361–366). The method was validated by a second laboratory and is proposed for inclusion in NMAM’s 5th Edition.

**FOR FURTHER INFORMATION CONTACT :**  Dale Shoemaker, Ph.D., NIOSH DART, 4676 Columbia Parkway MS R–7, Cincinnati, OH 45226. (513) 841–4523.

Dated: April 7, 2014. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.
[FR Doc. 2014–08141 Filed 4–10–14; 8:45 am]

**BILLING CODE 4163–19–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Board of Scientific Counselors, National Center for Health Statistics** 

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) announces the following meeting of the aforementioned committee:

Times and Dates: 11:00 a.m.–5:30 p.m., May 12, 2014, 8:30 a.m.–1:00 p.m., May 13,
2014

Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782.

Status: This meeting is open to the public; however, visitors must be processed in accordance with established federal policiesand procedures. For foreign nationals or nonUS citizens, pre-approval is required (please contact Gwen Mustaf, 301–458–4500, glm4@ cdc.gov, or Virginia Cain, vcain@cdc.gov at least 10 days in advance for requirements). All visitors are required to present a valid form of picture identification issued by a state, federal or international government. As required by the Federal Property Management Regulations, Title 41, Code of Federal Regulation, Subpart 101–20.301, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being x-rayed and inspected. Federal law prohibits the knowing possession or the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. The meeting room accommodates approximately 100 people.

Purpose: This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS.

Matters For Discussion: The agenda will include welcome remarks by the Director, NCHS; the March 4–5, 2014 Office of Analysis and Epidemiology Program Review; report from the February 10–11, 2014 National Academy of Sciences Workshop on Guidelines for Returning Individual Resultsfrom Genome Research Using PopulationBased Specimens; program updates.

Requests to make oral presentations should be submitted in writing to the contact person listed below. All requests must contain the name, address, telephone number, and organizational affiliation of the presenter.

Written comments should not exceed five single-spaced typed pages in length and must be received by April 25, 2014.

The agenda items are subject to change as priorities dictate.

Contact Person For More Information: Virginia S. Cain, Ph.D., Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 7208, Hyattsville, Maryland 20782, telephone (301) 458–4500, fax (301) 458–4020. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and the Agency for Toxic Substances and Disease Registry.
Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2014–08199 Filed 4–10–14; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Medicare & Medicaid Services** 

**[Document Identifiers: CMS–37, CMS–64, CMS–10320, CMS–10396, CMS–102 and**  **CMS–105, and CMS–367]**

**Agency Information Collection Activities: Submission for OMB**  **Review; Comment Request**

**ACTION :**  Notice.

**SUMMARY :**  The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995